2012
DOI: 10.1074/jbc.m111.298703
|View full text |Cite
|
Sign up to set email alerts
|

Interleukin 33 as a Mechanically Responsive Cytokine Secreted by Living Cells

Abstract: Background: Conflicting data describe Interleukin 33 as a nuclear factor and ligand for a transmembrane receptor complex. Results: IL-33 displays multi-compartmental geography, inter-organelle flux and extracellular release from mechanically stressed cells. Conclusion: IL-33 manifests dynamic subcellular mobility and secretion from living cells upon biomechanical strain. Significance: IL-33 belongs to a group of factors displaying dual inflammatory and mechano-responsive properties.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
142
1
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 258 publications
(150 citation statements)
references
References 20 publications
6
142
1
1
Order By: Relevance
“…However, it is unclear if cell death can account entirely for the biologic effects of IL-33. IL-33 release from living cells was reported in human bronchial epithelium exposed to Alternaria (Kouzaki et al, 2011) and from mechanically-stressed fibroblasts in vitro and in vivo (Kakkar et al, 2012). Several studies suggest extracellular ATP can promote IL-33 production or secretion in models of allergic inflammation(Byers et al, 2013; Hudson et al, 2008; Kouzaki et al, 2011).…”
Section: Il-33 Release And/or Secretionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, it is unclear if cell death can account entirely for the biologic effects of IL-33. IL-33 release from living cells was reported in human bronchial epithelium exposed to Alternaria (Kouzaki et al, 2011) and from mechanically-stressed fibroblasts in vitro and in vivo (Kakkar et al, 2012). Several studies suggest extracellular ATP can promote IL-33 production or secretion in models of allergic inflammation(Byers et al, 2013; Hudson et al, 2008; Kouzaki et al, 2011).…”
Section: Il-33 Release And/or Secretionmentioning
confidence: 99%
“…Inflammatory DCs also interact with fibroblastic reticular cells (FRC), which mediate lymph node remodeling and enlargement during infection (Acton et al, 2014). HEV and FRC are primary sources of lymph node IL-33 in mice and humans (Moussion et al, 2008; Pichery et al, 2012), and release of IL-33 in these cells might reflect mechanical forces inherent in the rapid inflammation-induced changes in lymph node size, akin to findings in fibroblasts (Kakkar et al, 2012). In contrast, ILC2s, mast cells and ST2 + Tregs are rare in lymphoid tissues (Molofsky et al, 2015; Nussbaum et al, 2013), potentially limiting competition for IL-33 and allowing IL-12 to drive low amounts of ST2 expression on inflammatory lymphocytes that enables competence to detect IL-33.…”
Section: Il-33-st2 In Infection and Non-allergic Inflammationmentioning
confidence: 99%
“…For example, IL-33, a potent ILC2 activator, is constitutively maintained in the nucleus of epithelial and endothelial cells as a pro-cytokine and released during necrosis or mechanical strain [52,53]. Therefore, by monitoring IL-33, ILC2s can promote eosinophil and AAM accumulation following local tissue damage, a response that the results discussed above suggest could mitigate tissue injury.…”
Section: Ilc2s: Integrating Homeostatic Signalsmentioning
confidence: 99%
“…However, it can be speculated as the follows reasons. First, the identification of a nuclear localization sequence in IL-33 suggests that IL-33 is released from dying cells into the extracellular matrix to signal damage (Bianchi 2007) or by cells undergoing mechanical stress (Kakkar et al 2012). IL-33 may serve this purpose after SAH, which is known to induce neuronal apoptosis, necrosis, and other types of injury (Charriaut-Marlangue et al 1996;Graham and Chen 2001).…”
Section: Discussionmentioning
confidence: 99%